Definitive Contract 75F40125C00085
Award Date
9/22/25
Potential Completion Date
9/29/26
Potential Value
$325K
Federal Agency
Food and Drug Administration
Awardee
Hartford Hospital
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Hartford, CT 06102, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a definitive contract between the Department of Health and Human Services' Food and Drug Administration (FDA) and Hartford Hospital, a non-profit hospital located in Hartford, Connecticut. The contract, valued at $249,975.00, is for research and development activities related to assessing the activity of the antibiotic cefepime against carbapenemase-producing Enterobacterales. This contract was awarded under the FDA's Broad Agency Announcement (BAA) for Advanced...
The Department of Health and Human Services Food and Drug Administration awarded a Firm Fixed Price Definitive Contract to Hartford Hospital, a non-profit hospital in Hartford, Connecticut, with a potential value of $249,794.00. The contract is for research related to "Metallo-B-Lactamase Resistance in Enterobacterales: Is It Time to Rethink Our In Vitro Assessment Tools?". This contract was issued under a Broad Agency Announcement (BAA) that solicits advanced research and...
The Department of Health and Human Services Food and Drug Administration awarded a $407,720 definitive contract to Hartford Hospital. The contract is for ex vivo modeling, simulation, and in vivo pharmacokinetic validation to guide antimicrobial dosing recommendations for patients on continuous renal replacement therapy. The contract has a start date of September 9, 2022 and end date of September 29, 2024, and utilizes a firm fixed price pricing structure. The place of performance is Hartford,...
The Department of Health and Human Services Food and Drug Administration awarded a $249,999.00 definitive contract to Hartford Hospital, a non-profit hospital organization, to conduct research and development in support of regulatory science and innovation. This contract was awarded under the FDA's Broad Agency Announcement for Advanced Regulatory Science for fiscal year 2021, which solicits proposals across eight areas of regulatory science to modernize FDA functions. The contract does not have...
This is a definitive contract awarded by the Department of Health and Human Services Food and Drug Administration (FDA) to Hartford Hospital, a non-profit hospital located in Hartford, Connecticut. The contract, with a potential value of $249,991.00, is for research on the pharmacodynamics of three antibiotics - minocycline, levofloxacin, and trimethoprim/sulfamethoxazole - against the bacterium Stenotrophomonas maltophilia. The goal of the research is to provide data to support potential...
This is a Firm Fixed Price definitive contract awarded by the Naval Supply Systems Command (NAVSUP) to Hartford Hospital, a non-profit healthcare institution in Hartford, Connecticut. The contract is for $3,900.00 and provides emergency medical training classes. The contract has an ultimate completion date of May 1, 2025 and was awarded on April 30, 2025. There is no set-aside designation indicated for this contract. Hartford Hospital has previously received federal grant awards, primarily...
This is a $539,764.16 firm fixed price purchase order awarded by the Department of the Navy's Bureau of Medicine and Surgery to Hartford Hospital, a non-profit 830-bed hospital in Hartford, Connecticut. The contract is for emergency medical simulation training services, with a performance period through May 14, 2023. Hartford Hospital has previously conducted research for the Food and Drug Administration and provided clinical services in support of multi-site studies funded by the National...
This is a $1,103,886.00 Firm Fixed Price contract awarded by the Food and Drug Administration (FDA), a civilian agency, to the University of Connecticut (UConn) to conduct research and development on the "Impact of API CQAS on In Situ Forming Implants and Understanding In Vitro and In Vivo Performance Differences". The contract has a completion date of September 29, 2026 and was awarded on September 22, 2023 with no set-aside designation. UConn is a prominent 1862 land-grant...
This is a $1,417,987.00 federal contract awarded by the Food and Drug Administration (FDA) to the University of Connecticut (UConn). The contract is a Definitive Contract without a set-aside designation. The contract involves a comparative trial of different packaging components of an opioid packaging solution to evaluate their impact on opioid safety outcomes. UConn is working with Hartford Hospital and the UConn Health Center as subcontractors on this research project, which aims to identify...
The federal contract award is for a definitive contract with the Food and Drug Administration (FDA) for human food inspection services in Hartford, Connecticut. The $372,314.29 firm fixed price contract was awarded on August 29, 2023 to the Connecticut Department of Consumer Protection, a U.S. state government entity, to provide these inspection services from August 2023 through March 2027. This contract was awarded without any set-asides. In addition to the contract award, the Department of...